Why The PacBio (PACB) Investment Story Is Shifting As Analysts Cut Targets And Flag Risks [Yahoo! Finance]
Pacific Biosciences of California, Inc. (PACB)
Last pacific biosciences of california, inc. earnings: 2/6 04:02 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investor.pacificbiosciences.com
Company Research
Source: Yahoo! Finance
Pacific Biosciences of California is back in focus after analysts cut their price target to $1.50 from $2, while a separate fair value estimate was trimmed to $2.43 from $2.50. This shift is tied to an Underweight rating, along with fresh worries about near term demand for sequencing consumables, growth visibility, and a possible pause in orders ahead of new competitive launches. Read on to see what these changes might mean for you and how to track the evolving story around the stock. Analyst Price Targets don't always capture the full story. Head over to our Company Report to find new ways to value Pacific Biosciences of California. What Wall Street Has Been Saying ?? Bullish Takeaways Barclays still assigns a specific price target to Pacific Biosciences of California, now at US$1.50, which gives investors a concrete reference point for how one major firm currently values the shares. The research highlights upcoming competitive launches and SPRQ NX as key industry events,
Show less
Read more
Impact Snapshot
Event Time:
PACB
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PACB alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PACB alerts
High impacting Pacific Biosciences of California, Inc. news events
Weekly update
A roundup of the hottest topics
PACB
News
- Pacific Biosciences of California (PACB) Dips More Than Broader Market: What You Should Know [Yahoo! Finance]Yahoo! Finance
- Could data from 100 million species help cure disease? One startup is betting on it [Yahoo! Finance]Yahoo! Finance
- Pacific Biosciences (PACB) Upgraded to Strong Buy: What Does It Mean for the Stock? [Yahoo! Finance]Yahoo! Finance
- Basecamp Research Selects PacBio HiFi Sequencing to Power Trillion Gene Atlas Initiative [Yahoo! Finance]Yahoo! Finance
- Life Sciences Tools & Services Stocks Q4 Earnings: Illumina (NASDAQ:ILMN) Firing on All Cylinders [Yahoo! Finance]Yahoo! Finance
PACB
Earnings
- 2/12/26 - Beat
PACB
Sec Filings
- 3/27/26 - Form SCHEDULE
- 3/6/26 - Form 8-K
- 3/5/26 - Form 4
- PACB's page on the SEC website